NEAT (European AIDS Treatment Network)

NEAT is a network of Excellence funded by the European Commission. Its mission is to strengthen European HIV clinical research capacity.

The main deliverables of NEAT are centered around clinical research (the NEAT001/ANRS 143 HIV clinical trial and its substudies, the NEAT HepC/HIV Cohort Network, intergration grants etc.) and training and education activities.

EATG is the HIV Community Partner in NEAT. EATG holds different positions within the Consortium and works to promote the interests of people living with HIV/AIDS.

In this section you can find a summary of all activities conducted by EATG since initiation of NEAT in February 2007 as well as the foreseen deliverables till the end of the project in January 2012.

NEAT 001 is a strategic trial investigating two different treatment combinations to treat HIV-1 infected patients that have never been treated for their HIV infection before. It compares a standard regimen of three drugs that is already recommended as first-line therapy (regimen for treatment naïve HIV-1 patients ) to an innovative treatment option that combines two potent recent antiretroviral drugs.

In this section you can find information leaflets and flyers about the NEAT001 / ANRS 143 clinical trial in different languages coresponding to the countries where the patients are recruited.

In case of questions you can contact Laure Sonnier (EATG Scientific Adviser)

It is a Network of major experts in the field of HIV / HCV coinfection working at establishing a cohort of patients for the PRospective OBservational Evaluation (PROBE) study on the natural history and treatment of acute HCV in HIV positive individuals in Europe.

Just click on: http://www.neat-noe.org